LIGAND PHARMACEUTICALS INC Insider Trading for December 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for December 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Payment of Exercise | F | 105.87 | 979 | 103,647 | 20,016 | 21 K to 20 K (-4.66 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Grant | A | 0.00 | 2,305 | 0 | 20,995 | 18.7 K to 21 K (+12.33 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Payment of Exercise | F | 105.87 | 1,135 | 120,162 | 18,690 | 19.8 K to 18.7 K (-5.73 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Grant | A | 0.00 | 2,674 | 0 | 19,825 | 17.2 K to 19.8 K (+15.59 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Payment of Exercise | F | 105.87 | 546 | 57,805 | 49,069 | 49.6 K to 49.1 K (-1.10 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 1,335 | 0 | 49,615 | 48.3 K to 49.6 K (+2.77 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Payment of Exercise | F | 105.87 | 585 | 61,934 | 48,280 | 48.9 K to 48.3 K (-1.20 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 1,693 | 0 | 48,865 | 47.2 K to 48.9 K (+3.59 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 105.87 | 1,444 | 152,876 | 148,337 | 149.8 K to 148.3 K (-0.96 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 2,913 | 0 | 149,781 | 146.9 K to 149.8 K (+1.98 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 105.87 | 2,210 | 233,973 | 146,868 | 149.1 K to 146.9 K (-1.48 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 4,458 | 0 | 149,078 | 144.6 K to 149.1 K (+3.08 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 105.87 | 2,948 | 312,105 | 153,614 | 156.6 K to 153.6 K (-1.88 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Grant | A | 0.00 | 5,946 | 0 | 156,562 | 150.6 K to 156.6 K (+3.95 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 105.87 | 3,801 | 402,412 | 150,616 | 154.4 K to 150.6 K (-2.46 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Grant | A | 0.00 | 7,668 | 0 | 154,417 | 146.7 K to 154.4 K (+5.23 %) |